Alkem Laboratories (India) Financial Indicators Patterns

ALKEM -- India Stock  

INR 1,887  54.20  0.03%

We suggest you to use Alkem Laboratories fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Alkem Laboratories is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty-one available fundamental indicators for Alkem Laboratories Limited which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Alkem Laboratories fundamentals including its Total Debt, Market Capitalization and the relationship between EBITDA and Earnings Per Share . Use Alkem Laboratories to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Alkem Laboratories to be traded at 1868.58 in 30 days.

Alkem Laboratories Company Summary

Alkem Laboratories competes with Sun Pharmaceutical, Aurobindo Pharma, Dr Reddys, Dr Reddys, and Divis Laboratories. Alkem Laboratories Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical and nutraceutical products in India, the United States, and internationally. The company was founded in 1973 and is headquartered in Mumbai, India. Alkem Laboratories operates under Drug Manufacturers - Specialty Generic classification in India and is traded on National Stock Exchange of India.

Alkem Laboratories Book Value Per Share vs Return On Equity

Alkem Laboratories Limited is rated third in book value per share category among related companies. It is rated below average in return on equity category among related companies reporting about  0.03  of Return On Equity per Book Value Per Share. The ratio of Book Value Per Share to Return On Equity for Alkem Laboratories Limited is roughly  34.54 

Alkem Laboratories Systematic Risk

The output start index for this execution was twelve with a total number of output elements of twenty-seven. The Beta measures systematic risk based on how returns on Alkem Laboratories correlated with the market. If Beta is less than 0 Alkem Laboratories generally moves in the opposite direction as compared to the market. If Alkem Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alkem Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alkem Laboratories is generally in the same direction as the market. If Beta > 1 Alkem Laboratories moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Alkem Laboratories Financial Distress Probability

Chance of Financial Distress
Alkem Laboratories Limited has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Alkem Laboratories Opportunity Range

January 20, 2019 Opportunity Range

Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.